Literature DB >> 33005619

Conjunctival Melanoma Angiotropic Microsatellitosis: A Mechanism of Local Extravascular Migratory Metastasis.

Jose J Echegaray1, Gabrielle Yeaney2, Rachel Chen1, Arun D Singh1.   

Abstract

PURPOSE: To report a case of local metastasis of conjunctival melanoma, which may occur via extravascular migratory metastasis (EVMM), and discuss its clinical relevance in conjunctival melanoma tumor staging and possible management implications.
METHODS: Retrospective chart review of a single clinical case with clinicopathologic correlation.
RESULTS: A 65-year-old male referred due to local recurrence of conjunctival melanoma at the caruncle was successfully treated after two excisional procedures with negative sentinel lymph node biopsies. Forty-eight months after initial presentation, the patient developed a nodular lesion representing local recurrence in the ipsilateral upper tarsal conjunctiva, distant from the primary tumor site. Histopathology showed nodules in the substantia propria in the absence of primary acquired melanosis. The tumor cells were found along the extravascular surface without intralymphatic or intravascular tumor cells consistent with local metastasis. One possible mechanism is angiotropic microsatellitosis leading to local EVMM. Additional neck CT imaging showed no lymphadenopathy.
CONCLUSION: EVMM via angiotropic microsatellitosis is another possible mechanism of noncontiguous local recurrence of conjunctival melanoma. Angiotropic microsatellitosis may represent a high-risk finding possibly related to increased melanoma-related mortality.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Angiotropism; Conjunctival melanoma; Extravascular migratory metastasis; Local metastasis; Microsatellitosis

Year:  2020        PMID: 33005619      PMCID: PMC7506277          DOI: 10.1159/000505270

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  19 in total

1.  Melanoma and extravascular migratory metastasis.

Authors:  C Lugassy; R L Barnhill; L Christensen
Journal:  J Cutan Pathol       Date:  2000-10       Impact factor: 1.587

2.  Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.

Authors:  Ludwig M Heindl; Carmen Hofmann-Rummelt; Werner Adler; Jacobus J Bosch; Leonard M Holbach; Gottfried O H Naumann; Friedrich E Kruse; Claus Cursiefen
Journal:  Ophthalmology       Date:  2011-08-11       Impact factor: 12.079

3.  Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.

Authors:  B Esmaeli; X Wang; A Youssef; J E Gershenwald
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

4.  Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features.

Authors:  Aaron Savar; Bita Esmaeli; Hao Ho; Suyu Liu; Victor G Prieto
Journal:  J Cutan Pathol       Date:  2010-09-23       Impact factor: 1.587

5.  Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.

Authors:  Yacoub A Yousef; Paul T Finger
Journal:  Arch Ophthalmol       Date:  2012-05

6.  Conjunctival melanoma in the Netherlands: a nationwide study.

Authors:  Guy S Missotten; Sander Keijser; Rob J W De Keizer; Didi De Wolff-Rouendaal
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

7.  Time trends in the incidence of conjunctival melanoma in Sweden.

Authors:  E Triay; L Bergman; B Nilsson; C All-Ericsson; S Seregard
Journal:  Br J Ophthalmol       Date:  2009-07-23       Impact factor: 4.638

8.  American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes.

Authors:  Carol L Shields; Swathi Kaliki; Saad A Al-Dahmash; Sara E Lally; Jerry A Shields
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Sep-Oct       Impact factor: 1.746

9.  Metastatic melanoma within and to the conjunctiva.

Authors:  F A Jakobiec; G Buckman; L E Zimmerman; F G La Piana; M R Levine; A P Ferry; J B Crawford
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

10.  Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

Authors:  Jeffrey Weber; Mario Mandala; Michele Del Vecchio; Helen J Gogas; Ana M Arance; C Lance Cowey; Stéphane Dalle; Michael Schenker; Vanna Chiarion-Sileni; Ivan Marquez-Rodas; Jean-Jacques Grob; Marcus O Butler; Mark R Middleton; Michele Maio; Victoria Atkinson; Paola Queirolo; Rene Gonzalez; Ragini R Kudchadkar; Michael Smylie; Nicolas Meyer; Laurent Mortier; Michael B Atkins; Georgina V Long; Shailender Bhatia; Celeste Lebbé; Piotr Rutkowski; Kenji Yokota; Naoya Yamazaki; Tae M Kim; Veerle de Pril; Javier Sabater; Anila Qureshi; James Larkin; Paolo A Ascierto
Journal:  N Engl J Med       Date:  2017-09-10       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.